Building a foundation model (4th or 5th place) is economically questionable because it costs pharmaceutical-company-scale capex but lacks pharmaceutical-company-scale returns, resulting in a misaligned cost structure and leading to consolidation of model-building into a small number of well-capitalized companies.
causalpending
Speaker
Brett TaylorEvidence Quote
“if you're pre-training a foundation model that's the fourth best uh that's going to cost you a lot of money and the return on that investment is is probably fairly questionable because why use your fourth best large language model versus a frontier model or an open- source one”
Created: 8/10/2026, 11:10:06 PM
Your notes
Loading notes...